Logo for Portage Biotech Inc.
PBT.U

Portage Biotech Inc.

Statut
delisted
Émis et en Circulation10,987,706
Réservé pour Émission5,958
Devise
CSE Indice

À propos

Portage Biotech Inc.

Date d'inscription
28 octobre 2013

Portage is engaged in researching and developing pharmaceutical and biotech products through to clinical "proof of concept" with an initial focus on unmet clinical needs and orphan drugs. Following proof of concept, Portage will look to sell or license the products to large pharmaceutical companies for further development and commercialization.

* TRADES IN USD *